rdc-DiagnosticReport-bgm-report
{
},
{
}
]
},
{
},
{
}
]
},
},
}
},
{
},
{
}
]
},
},
}
},
{
},
{
}
]
},
},
}
},
{
},
{
}
]
},
},
}
},
{
},
{
}
]
},
},
}
},
{
},
{
"display": "BGM Time above range, very high, % of readings and time >250 mg/dL (>13.9 mmol/L), during reporting period"
}
]
},
},
}
},
{
},
{
"display": "BGM Time above range, high, % of readings and time 181–250 mg/ dL (10.1–13.9 mmol/L), during reporting period"
}
]
},
},
}
},
{
},
{
"display": "BGM Time in range, % of readings and time 70–180 mg/dL (3.9– 10.0 mmol/L), during reporting period"
}
]
},
},
}
},
{
},
{
"display": "BGM Time below range, low, % of readings and time 54–69 mg/dL (3.0–3.8 mmol/L), during reporting period"
}
]
},
},
}
},
{
},
{
"display": "BGM Time below range, very low, % of readings and time <54 mg/dL (<3.0 mmol/L), during reporting period"
}
]
},
},
}
}
],
},
},
],
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
}
],
{
}
]
}
</meta>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="Glucose Standard Deviation [Mass/volume] in Capillary blood, during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="BGM Time above range, very high, % of readings and time >250 mg/dL (>13.9 mmol/L), during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="BGM Time above range, high, % of readings and time 181–250 mg/ dL (10.1–13.9 mmol/L), during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="BGM Time in range, % of readings and time 70–180 mg/dL (3.9– 10.0 mmol/L), during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="BGM Time below range, low, % of readings and time 54–69 mg/dL (3.0–3.8 mmol/L), during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="BGM Time below range, very low, % of readings and time <54 mg/dL (<3.0 mmol/L), during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
</coding>
</code>
</subject>
</effectivePeriod>
</performer>
</performer>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</presentedForm>
</DiagnosticReport>
DiagnosticReport |
id : rdc-DiagnosticReport-bgm-report |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-DiagnosticReport |
status : final |
code |
coding |
code : R3125-2 |
system : https://roche.com/fhir/CodeSystem/general |
display : Blood Glucose Monitoring (BGM) Report During Reporting Period |
contained |
id : Obs-1 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R4615-4 |
system : https://roche.com/fhir/CodeSystem/general |
display : Average glucose [Mass/volume] in Capillary blood, during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : mg/dL |
unit : mg/dL |
value : 78 |
contained |
id : Obs-2 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R7533-3 |
system : https://roche.com/fhir/CodeSystem/general |
display : Glucose Standard Deviation [Mass/volume] in Capillary blood, during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : mg/dL |
unit : mg/dL |
value : 22 |
contained |
id : Obs-3 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R4686-2 |
system : https://roche.com/fhir/CodeSystem/general |
display : BGM Glycemic Variability (%GV), during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : % |
unit : % |
value : 128.2 |
contained |
id : Obs-4 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R4614-4 |
system : https://roche.com/fhir/CodeSystem/general |
display : Total number of Finger-prick sampling per day |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : {count}/d |
value : 2 |
contained |
id : Obs-5 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R7534-3 |
system : https://roche.com/fhir/CodeSystem/general |
display : Total number of Finger-prick sampling, during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : {count} |
value : 28 |
contained |
id : Obs-6 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R6599-5 |
system : https://roche.com/fhir/CodeSystem/general |
display : BGM Time above range, very high, % of readings and time >250 mg/dL (>13.9 mmol/L), during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : % |
unit : % |
value : 0 |
contained |
id : Obs-7 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R4843-9 |
system : https://roche.com/fhir/CodeSystem/general |
display : BGM Time above range, high, % of readings and time 181–250 mg/ dL (10.1–13.9 mmol/L), during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : % |
unit : % |
value : 0 |
contained |
id : Obs-8 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R7925-1 |
system : https://roche.com/fhir/CodeSystem/general |
display : BGM Time in range, % of readings and time 70–180 mg/dL (3.9– 10.0 mmol/L), during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : % |
unit : % |
value : 50 |
contained |
id : Obs-9 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R5422-1 |
system : https://roche.com/fhir/CodeSystem/general |
display : BGM Time below range, low, % of readings and time 54–69 mg/dL (3.0–3.8 mmol/L), during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : % |
unit : % |
value : 50 |
contained |
id : Obs-10 |
meta |
profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
status : final |
code |
coding |
code : R7572-1 |
system : https://roche.com/fhir/CodeSystem/general |
display : BGM Time below range, very low, % of readings and time <54 mg/dL (<3.0 mmol/L), during reporting period |
effective |
start : 2020-10-15T02:01:00+01:00 |
end : 2020-10-15T02:06:00+01:00 |
value |
system : http://unitsofmeasure.org |
code : % |
unit : % |
value : 0 |
subject |
reference : Patient-Reference |
effective |
start : 2023-10-03T06:32:00+01:00 |
end : 2023-10-03T07:30:00+01:00 |
performer |
reference : Organization-Reference |
performer |
reference : Practitioner-Reference |
result |
reference : #Obs-1 |
result |
reference : #Obs-2 |
result |
reference : #Obs-3 |
result |
reference : #Obs-4 |
result |
reference : #Obs-5 |
result |
reference : #Obs-6 |
result |
reference : #Obs-7 |
result |
reference : #Obs-8 |
result |
reference : #Obs-9 |
result |
reference : #Obs-10 |
presentedForm |
url : https://aws-cloud-location-of-AGP-Report |
data : QUdQIHJlcG9ydA== |
hash : 2c9fa2fc8f4fd1b3184821e27dfc0b6960724633 |
contentType : application/pdf |
creation : 2023-10-03T07:30:00+01:00 |
title : AGP-Report |
DiagnosticReport.id[0] | rdc-DiagnosticReport-bgm-report |
DiagnosticReport.meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-DiagnosticReport |
DiagnosticReport.contained[0].id[0] | Obs-1 |
DiagnosticReport.contained[0].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[0].status[0] | final |
DiagnosticReport.contained[0].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[0].code[0].coding[0].code[0] | R4615-4 |
DiagnosticReport.contained[0].code[0].coding[0].display[0] | Average glucose [Mass/volume] in Capillary blood, during reporting period |
DiagnosticReport.contained[0].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[0].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[0].value[0].value[0] | 78 |
DiagnosticReport.contained[0].value[0].unit[0] | mg/dL |
DiagnosticReport.contained[0].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[0].value[0].code[0] | mg/dL |
DiagnosticReport.contained[1].id[0] | Obs-2 |
DiagnosticReport.contained[1].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[1].status[0] | final |
DiagnosticReport.contained[1].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[1].code[0].coding[0].code[0] | R7533-3 |
DiagnosticReport.contained[1].code[0].coding[0].display[0] | Glucose Standard Deviation [Mass/volume] in Capillary blood, during reporting period |
DiagnosticReport.contained[1].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[1].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[1].value[0].value[0] | 22 |
DiagnosticReport.contained[1].value[0].unit[0] | mg/dL |
DiagnosticReport.contained[1].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[1].value[0].code[0] | mg/dL |
DiagnosticReport.contained[2].id[0] | Obs-3 |
DiagnosticReport.contained[2].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[2].status[0] | final |
DiagnosticReport.contained[2].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[2].code[0].coding[0].code[0] | R4686-2 |
DiagnosticReport.contained[2].code[0].coding[0].display[0] | BGM Glycemic Variability (%GV), during reporting period |
DiagnosticReport.contained[2].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[2].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[2].value[0].value[0] | 128.2 |
DiagnosticReport.contained[2].value[0].unit[0] | % |
DiagnosticReport.contained[2].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[2].value[0].code[0] | % |
DiagnosticReport.contained[3].id[0] | Obs-4 |
DiagnosticReport.contained[3].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[3].status[0] | final |
DiagnosticReport.contained[3].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[3].code[0].coding[0].code[0] | R4614-4 |
DiagnosticReport.contained[3].code[0].coding[0].display[0] | Total number of Finger-prick sampling per day |
DiagnosticReport.contained[3].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[3].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[3].value[0].value[0] | 2 |
DiagnosticReport.contained[3].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[3].value[0].code[0] | {count}/d |
DiagnosticReport.contained[4].id[0] | Obs-5 |
DiagnosticReport.contained[4].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[4].status[0] | final |
DiagnosticReport.contained[4].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[4].code[0].coding[0].code[0] | R7534-3 |
DiagnosticReport.contained[4].code[0].coding[0].display[0] | Total number of Finger-prick sampling, during reporting period |
DiagnosticReport.contained[4].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[4].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[4].value[0].value[0] | 28 |
DiagnosticReport.contained[4].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[4].value[0].code[0] | {count} |
DiagnosticReport.contained[5].id[0] | Obs-6 |
DiagnosticReport.contained[5].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[5].status[0] | final |
DiagnosticReport.contained[5].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[5].code[0].coding[0].code[0] | R6599-5 |
DiagnosticReport.contained[5].code[0].coding[0].display[0] | BGM Time above range, very high, % of readings and time >250 mg/dL (>13.9 mmol/L), during reporting period |
DiagnosticReport.contained[5].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[5].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[5].value[0].value[0] | 0 |
DiagnosticReport.contained[5].value[0].unit[0] | % |
DiagnosticReport.contained[5].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[5].value[0].code[0] | % |
DiagnosticReport.contained[6].id[0] | Obs-7 |
DiagnosticReport.contained[6].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[6].status[0] | final |
DiagnosticReport.contained[6].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[6].code[0].coding[0].code[0] | R4843-9 |
DiagnosticReport.contained[6].code[0].coding[0].display[0] | BGM Time above range, high, % of readings and time 181–250 mg/ dL (10.1–13.9 mmol/L), during reporting period |
DiagnosticReport.contained[6].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[6].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[6].value[0].value[0] | 0 |
DiagnosticReport.contained[6].value[0].unit[0] | % |
DiagnosticReport.contained[6].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[6].value[0].code[0] | % |
DiagnosticReport.contained[7].id[0] | Obs-8 |
DiagnosticReport.contained[7].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[7].status[0] | final |
DiagnosticReport.contained[7].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[7].code[0].coding[0].code[0] | R7925-1 |
DiagnosticReport.contained[7].code[0].coding[0].display[0] | BGM Time in range, % of readings and time 70–180 mg/dL (3.9– 10.0 mmol/L), during reporting period |
DiagnosticReport.contained[7].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[7].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[7].value[0].value[0] | 50 |
DiagnosticReport.contained[7].value[0].unit[0] | % |
DiagnosticReport.contained[7].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[7].value[0].code[0] | % |
DiagnosticReport.contained[8].id[0] | Obs-9 |
DiagnosticReport.contained[8].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[8].status[0] | final |
DiagnosticReport.contained[8].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[8].code[0].coding[0].code[0] | R5422-1 |
DiagnosticReport.contained[8].code[0].coding[0].display[0] | BGM Time below range, low, % of readings and time 54–69 mg/dL (3.0–3.8 mmol/L), during reporting period |
DiagnosticReport.contained[8].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[8].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[8].value[0].value[0] | 50 |
DiagnosticReport.contained[8].value[0].unit[0] | % |
DiagnosticReport.contained[8].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[8].value[0].code[0] | % |
DiagnosticReport.contained[9].id[0] | Obs-10 |
DiagnosticReport.contained[9].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
DiagnosticReport.contained[9].status[0] | final |
DiagnosticReport.contained[9].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.contained[9].code[0].coding[0].code[0] | R7572-1 |
DiagnosticReport.contained[9].code[0].coding[0].display[0] | BGM Time below range, very low, % of readings and time <54 mg/dL (<3.0 mmol/L), during reporting period |
DiagnosticReport.contained[9].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
DiagnosticReport.contained[9].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
DiagnosticReport.contained[9].value[0].value[0] | 0 |
DiagnosticReport.contained[9].value[0].unit[0] | % |
DiagnosticReport.contained[9].value[0].system[0] | http://unitsofmeasure.org |
DiagnosticReport.contained[9].value[0].code[0] | % |
DiagnosticReport.status[0] | final |
DiagnosticReport.code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
DiagnosticReport.code[0].coding[0].code[0] | R3125-2 |
DiagnosticReport.code[0].coding[0].display[0] | Blood Glucose Monitoring (BGM) Report During Reporting Period |
DiagnosticReport.subject[0].reference[0] | Patient-Reference |
DiagnosticReport.effective[0].start[0] | 2023-10-03T06:32:00+01:00 |
DiagnosticReport.effective[0].end[0] | 2023-10-03T07:30:00+01:00 |
DiagnosticReport.performer[0].reference[0] | Organization-Reference |
DiagnosticReport.performer[1].reference[0] | Practitioner-Reference |
DiagnosticReport.result[0].reference[0] | #Obs-1 |
DiagnosticReport.result[1].reference[0] | #Obs-2 |
DiagnosticReport.result[2].reference[0] | #Obs-3 |
DiagnosticReport.result[3].reference[0] | #Obs-4 |
DiagnosticReport.result[4].reference[0] | #Obs-5 |
DiagnosticReport.result[5].reference[0] | #Obs-6 |
DiagnosticReport.result[6].reference[0] | #Obs-7 |
DiagnosticReport.result[7].reference[0] | #Obs-8 |
DiagnosticReport.result[8].reference[0] | #Obs-9 |
DiagnosticReport.result[9].reference[0] | #Obs-10 |
DiagnosticReport.presentedForm[0].contentType[0] | application/pdf |
DiagnosticReport.presentedForm[0].data[0] | QUdQIHJlcG9ydA== |
DiagnosticReport.presentedForm[0].url[0] | https://aws-cloud-location-of-AGP-Report |
DiagnosticReport.presentedForm[0].hash[0] | 2c9fa2fc8f4fd1b3184821e27dfc0b6960724633 |
DiagnosticReport.presentedForm[0].title[0] | AGP-Report |
DiagnosticReport.presentedForm[0].creation[0] | 2023-10-03T07:30:00+01:00 |